The first clinical trial for a new COVID-19 vaccine developed by a U.S. biotech firm will begin in April at NIAID’s clinical-trials unit in Bethesda
n Monday, when China reported 409 new cases of COVID-19 infection and 150 more deaths, Massachusetts-based biotechnology company Moderna, Inc. delivered the first batch of its rapidly developed coronavirus vaccine to the U.S. National Institutes of Health (NIH). As of early Tuesday afternoon, Hong Kong time, there are 80,147 confirmed cases of COVID-19 and 2,699 deaths. In